Enovis (NYSE:ENOV) Releases FY 2025 Earnings Guidance

Enovis (NYSE:ENOV - Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 2.950-3.100 for the period, compared to the consensus earnings per share estimate of 3.180. The company issued revenue guidance of $2.2 billion-$2.3 billion, compared to the consensus revenue estimate of $2.2 billion.

Enovis Trading Down 0.1 %

Shares of Enovis stock traded down $0.03 during trading on Friday, hitting $33.05. The company's stock had a trading volume of 1,748,093 shares, compared to its average volume of 768,536. The stock has a market cap of $1.89 billion, a price-to-earnings ratio of -15.09 and a beta of 1.79. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.27 and a quick ratio of 1.12. Enovis has a 52 week low of $29.32 and a 52 week high of $53.84. The stock has a 50-day moving average price of $35.20 and a two-hundred day moving average price of $41.57.

Enovis (NYSE:ENOV - Get Free Report) last released its quarterly earnings data on Thursday, May 8th. The company reported $0.81 EPS for the quarter, beating the consensus estimate of $0.74 by $0.07. Enovis had a positive return on equity of 4.39% and a negative net margin of 5.95%. The firm had revenue of $558.83 million during the quarter, compared to the consensus estimate of $558.80 million. During the same quarter in the previous year, the company posted $0.50 earnings per share. The company's quarterly revenue was up 8.2% on a year-over-year basis. Equities research analysts anticipate that Enovis will post 2.79 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. JMP Securities reduced their target price on Enovis from $62.00 to $55.00 and set a "market outperform" rating on the stock in a report on Friday. Needham & Company LLC reduced their price target on shares of Enovis from $64.00 to $57.00 and set a "buy" rating for the company in a research note on Friday.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.